机构:
CHU Jean Minjoz, Serv Ophtalmol, 2 Blvd Fleming, F-25030 Besancon, FranceCHU Jean Minjoz, Serv Ophtalmol, 2 Blvd Fleming, F-25030 Besancon, France
Gauthier, A-S
[1
]
Noureddine, S.
论文数: 0引用数: 0
h-index: 0
机构:
CHU Jean Minjoz, Serv Ophtalmol, 2 Blvd Fleming, F-25030 Besancon, FranceCHU Jean Minjoz, Serv Ophtalmol, 2 Blvd Fleming, F-25030 Besancon, France
Noureddine, S.
[1
]
Delbosc, B.
论文数: 0引用数: 0
h-index: 0
机构:
CHU Jean Minjoz, Serv Ophtalmol, 2 Blvd Fleming, F-25030 Besancon, France
Fac Med & Pharm, 20 Rue Ambroise Pare, F-25000 Besancon, FranceCHU Jean Minjoz, Serv Ophtalmol, 2 Blvd Fleming, F-25030 Besancon, France
Delbosc, B.
[1
,2
]
机构:
[1] CHU Jean Minjoz, Serv Ophtalmol, 2 Blvd Fleming, F-25030 Besancon, France
[2] Fac Med & Pharm, 20 Rue Ambroise Pare, F-25000 Besancon, France
来源:
JOURNAL FRANCAIS D OPHTALMOLOGIE
|
2019年
/
42卷
/
06期
Interstitial keratitis is a non-ulcerative, non-suppurative, more or less vascularized inflammation of the corneal stroma. The corneal lesions result from the host response to bacterial, viral (40% of cases) or parasitic antigens, or from an autoimmune response (1% of cases) without active corneal infection. The natural history of the disease is divided into two phases: acute and cicatricial. This type of keratitis is less common than ulcerative bacterial keratitis, but it is a non-negligible cause of visual loss. It is associated with systemic or infectious disease and requires early diagnosis and appropriate treatment to optimize visual prognosis and avoid other complications. (C) 2019 Elsevier Masson SAS. All rights reserved.